0.7921
Precedente Chiudi:
$0.8873
Aprire:
$0.88
Volume 24 ore:
121.54K
Relative Volume:
0.44
Capitalizzazione di mercato:
$806.37K
Reddito:
$208.00K
Utile/perdita netta:
$-16.89M
Rapporto P/E:
-0.0379
EPS:
-20.8847
Flusso di cassa netto:
$-16.44M
1 W Prestazione:
-28.64%
1M Prestazione:
-65.11%
6M Prestazione:
-92.92%
1 anno Prestazione:
-99.25%
Glucotrack Inc Stock (GCTK) Company Profile
Nome
Glucotrack Inc
Settore
Industria
Telefono
972 (8) 675-7878
Indirizzo
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
GCTK
Glucotrack Inc
|
0.7921 | 806.37K | 208.00K | -16.89M | -16.44M | -20.88 |
|
ABT
Abbott Laboratories
|
104.66 | 181.09B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
95.60 | 122.29B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
293.07 | 112.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.84 | 63.53B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.62 | 49.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Glucotrack Inc Borsa (GCTK) Ultime notizie
Form 8K GlucoTrack Inc For: 28 September - Investing.com India
GlucoTrack Announces Debt-Reducing Public Equity Offering - theglobeandmail.com
Form 424B5 GlucoTrack Inc For: 24 September By Investing.com - Investing.com Canada
Medical device developer Glucotrack Inc. announces pricing of $3M public offering - ROI-NJ
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - Yahoo Finance
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering - Business Wire
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - Benzinga
Glucotrack (NASDAQ: GCTK) registers shares equal to 5,442% of stock outstanding - Stock Titan
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com India
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com UK
Shareholders at Glucotrack (GCTK) sign off on new financing-linked share issuances - Stock Titan
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com India
Glucotrack Prices $11.5 Million Convertible Note Financing - minichart.com.sg
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Nigeria
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com South Africa
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Australia
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Canada
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com UK
Glucotrack Closes $11.6M Senior Secured Convertible Notes; Generates $4.5M Cash in Private Placement - TradingView
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com South Africa
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Nigeria
Glucotrack Secures $11.5 Million Convertible Debt Financing - citybiz
Glucotrack secures $11.5M in convertible note financing - Investing.com
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com India
Glucotrack secures $11.5M in convertible note financing By Investing.com - Investing.com Canada
Glucotrack Announces $11.5 Million Financing - Finviz
Glucotrack Announces $11.5 Million Financing - marketscreener.com
Glucotrack Announces $11.5 Million Financing - Yahoo Finance
Why Does Glucotrack (NASDAQ:GCTK) Stand Out This Session? - kalkinemedia.com
GlucoTrack, Inc. announced that it has received $9.045015 million in funding - marketscreener.com
Glucotrack Strikes Settlement With Alto; $2M Cash Plus $2M Convertible Note at 5% - TradingView
Articles from Glucotrack - FinancialContent
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - kalkinemedia.com
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - 01net
Lōkahi Therapeutics Expands ai² Into Three Opportunity-Creating Business Divisions - Finviz
Lōkahi Therapeutics™ Expands ai² Into Three Opportunity-Creating Business Divisions - Stock Titan
GlucoTrack Inc (GCTK) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glucotrack (NASDAQ: GCTK) Announces White Lion Capital's 9.99% Stake Comprising 79,734 Shares - kalkinemedia.com
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
Near-10% Glucotrack (GCTK) holder faces ~5% cap unless limits raised - Stock Titan
Why Is the Market Watching Glucotrack? (NASDAQ:GCTK) - Kalkine Media
Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Collaboration with San Diego State University Fowler College of Business - FinancialContent
Lōkahi Therapeutics Expands Ai2 Futures Lab Asset Origination Network Through Collaboration With San Diego State University Fowler College of Business - Moomoo
What Is Driving Glucotrack Stock? (NASDAQ:GCTK) - Kalkine Media
GlucoTrack Inc (GCTK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Glucotrack (NASDAQ: GCTK) Executes 1-for-15 Reverse Stock Split, Reducing Shares to About 798,144 - Kalkine Media
What Is Driving Glucotrack Stock? - Kalkine Media
Glucotrack Inc Azioni (GCTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):